US Patent Issued to Janssen Biotech on July 28 for "Prostate neoantigens and their uses" (Pennsylvania, California, New Jersey Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,513, issued on July 28, was assigned to Janssen Biotech Inc. (Horsham, Pa.).

"Prostate neoantigens and their uses" was invented by Jason Lee DeHart (San Diego), Vipul Bhargava (Warrington, Pa.), Patrick Wilkinson (Collegeville, Pa.) and Manuel Alejandro Sepulveda (West Windsor, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are self-replicating RNA molecules encoding prostate neoantigens, vaccines, and method of treating and preventing prostate cancer using the self-replicating RNA molecules and vaccines."

The patent was filed on July 2, 2021, under Application No. 17/366,545.

*For further information, including images, chart...